CoChat

Vaccination of Alzheimer's model mice with Aβ derivative in alum adjuvant reduces Aβ burden without microhemorrhages

Open access
Asuni, Ayodeji A., Boutajangout, Allal, Scholtzova, Henrieta, Knudsen, Elin, Li, Yong Sheng, Quartermain, David, Frangione, Blas, Wisniewski, Thomas, Sigurdsson, Einar M. · 2006 · European Journal of Neuroscience
Cited by 91

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Abstract

Immunotherapy holds great promise for Alzheimer's disease (AD) and other conformational disorders but certain adverse reactions need to be overcome. The meningoencephalitis observed in the first AD vaccination trial was likely related to excessive cell‐mediated immunity caused by the immunogen, amyloid‐β (Aβ) 1–42, and the adjuvant, QS−21. To avoid this toxicity, we have been using Aβ derivatives in alum adjuvant that promotes humoral immunity. Other potential side effects of immunotherapy are increased vascular amyloid and associated microhemorrhages that may be related to rapid clearance of parenchymal amyloid. Here, we determined if our immunization strategy was associated with this form of toxicity, and if the therapeutic effect was age‐dependent. Tg2576 mice and wild‐type littermates were immunized from 11 or 19 months and their behaviour evaluated prior to killing at 24 months. Subsequently, plaque‐ and vascular‐Aβ burden, Aβ levels and associated pathology was assessed. The therapy started at the cusp of amyloidosis reduced cortical Aβ deposit burden by 31% and Aβ levels by 30–37%, which was associated with cognitive improvements. In contrast, treatment from 19 months, when pathology is well established, was not immunogenic and therefore did not reduce Aβ burden or improve cognition. Significantly, the immunotherapy in the 11–24 months treatment group, that reduced Aβ burden, did not increase cerebral bleeding or vascular Aβ deposits in contrast to several Aβ antibody studies. These findings indicate that our approach age‐dependently improves cognition and reduces Aβ burden when used with an adjuvant suitable for humans, without increasing vascular Aβ deposits or microhemorrhages.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1460-9568.2006.05149.x

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Research works printed but not linked: 40

  1. 10.1177/42.8.8027523 · DOI · Paper page
  2. 10.4049/jimmunol.174.3.1580 · DOI · Paper page
  3. 10.1212/01.WNL.0000150527.24596.29 · DOI
  4. 10.1523/JNEUROSCI.19-08-03248.1999 · DOI · Paper page
  5. 10.1002/jnr.10721 · DOI · Paper page
  6. 10.1016/S0197-4580(01)00245-7 · DOI
  7. 10.3758/BF03211017 · DOI
  8. 10.1111/j.1750-3639.2004.tb00493.x · DOI · Paper page
  9. 10.1073/pnas.0404866101 · DOI · Paper page
  10. 10.1016/S0169-409X(98)00008-8 · DOI · Paper page
  11. 10.1080/00221309.1946.10544520 · DOI · Paper page
  12. 10.1016/S0896-6273(03)00294-0 · DOI · Paper page
  13. 10.1126/science.274.5284.99 · DOI · Paper page
  14. 10.1002/1098-2302(2001)38:1<33::AID-DEV3>3.0.CO;2-0 · DOI
  15. Jameson B.A., 1988, The antigenic index: a novel algorithm for predicting antigenic determinants, Comput. Appl. Biosci., 4, 181
  16. 10.1016/j.neuroscience.2004.09.055 · DOI
  17. Kim K.S., 1990, Detection and quantification of amyloid β‐peptide with 2 monoclonal antibodies, Neurosci. Res. Comm., 7, 113
  18. 10.1002/ana.20009 · DOI · Paper page
  19. 10.1016/j.febslet.2005.03.070 · DOI · Paper page
  20. 10.1023/A:1023203122036 · DOI
  21. 10.1172/JCI25410 · DOI · Paper page
  22. 10.1212/01.WNL.0000148590.39911.DF · DOI · Paper page
  23. 10.1038/35050116 · DOI · Paper page
  24. 10.1037/h0083542 · DOI · Paper page
  25. Schmidt S.D., 2005, Amyloid Proteins: Methods and Protocols, 267
  26. Schmidt S.D., 2005, Amyloid Proteins: Methods and Protocols, 279
  27. Scholtzova H., 2002, Safety of potential vaccines for Alzheimer's disease, Soc. Neurosci. Abstr, 227.1
  28. 10.3758/CABN.1.1.83 · DOI
  29. Sigurdsson E.M., 2005, Histological staining of amyloid‐β in mouse brains, Meth. Mol. Biol., 299, 299
  30. 10.2174/138161206777698837 · DOI · Paper page
  31. Sigurdsson E.M., 2006, A non‐toxic ligand for voxel‐based MRI analysis of plaques in AD transgenic mice, Neurobiol. Aging
  32. 10.1523/JNEUROSCI.1344-04.2004 · DOI · Paper page
  33. 10.1016/S0197-4580(96)00169-8 · DOI
  34. 10.1016/S0002-9440(10)61715-4 · DOI · Paper page
  35. 10.1016/0306-4522(94)90010-8 · DOI · Paper page
  36. 10.1002/mrm.10529 · DOI · Paper page
  37. 10.1111/j.0105-2896.2005.00264.x · DOI · Paper page
  38. 10.1016/S0166-2236(98)01362-9 · DOI · Paper page
  39. 10.1186/1742-2094-1-24 · DOI
  40. 10.1111/j.1750-3639.2005.tb00102.x · DOI · Paper page

Cited by

See all 91

Metadata

Authors
Asuni, A. A., Boutajangout, A., Scholtzova, H., Knudsen, E., Li, Y. S., Quartermain, D., Frangione, B., Wisniewski, T., & Sigurdsson, E. M.
Venue
European Journal of Neuroscience
Publisher
Wiley
Published
2006-11
Volume
24
Issue
9
Pages
2530-2542
ISSN
  • 0953-816X (ISSN-L)
  • 1460-9568
OpenAlex
W1529100127
Cited by
91
References
10
FWCI
4.31
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Vaccination of Alzheimer's model mice with Aβ derivative in alum adjuvant reduces Aβ burden without microhemorrhages. https://app.cochat.ai/papers/10.1111/j.1460-9568.2006.05149.x
The paper
Asuni, A. A., Boutajangout, A., Scholtzova, H., Knudsen, E., Li, Y. S., Quartermain, D., Frangione, B., Wisniewski, T., & Sigurdsson, E. M. (2006). Vaccination of Alzheimer's model mice with Aβ derivative in alum adjuvant reduces Aβ burden without microhemorrhages. European Journal of Neuroscience. https://doi.org/10.1111/j.1460-9568.2006.05149.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.